-
Je něco špatně v tomto záznamu ?
Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme
O. Majek, J. Danes, M. Skovajsova, H. Bartonkova, L. Buresova, D. Klimes, P. Brabec, P. Kozeny, L. Dusek,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10650
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
BioMedCentral
od 2001-01-12
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-01-01
Health & Medicine (ProQuest)
od 2009-01-01
Public Health Database (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
PubMed
21554747
DOI
10.1186/1471-2458-11-288
Knihovny.cz E-zdroje
- MeSH
- hodnocení programu MeSH
- lidé středního věku MeSH
- lidé MeSH
- mamografie využití MeSH
- nádory prsu diagnóza MeSH
- plošný screening organizace a řízení využití MeSH
- podpora zdraví MeSH
- registrace MeSH
- senioři MeSH
- ukazatele kvality zdravotní péče MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. METHODS: The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring. RESULTS: Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines. CONCLUSIONS: Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.
Institute of Biostatistics and Analyses Masaryk University Kamenice 126 3 625 00 Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028331
- 003
- CZ-PrNML
- 005
- 20141006172657.0
- 007
- ta
- 008
- 120817e20110510enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1186/1471-2458-11-288 $2 doi
- 035 __
- $a (PubMed)21554747
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Májek, Ondřej $7 xx0156444 $u Institute of Biostatistics and Analyses, Masaryk University, Kamenice 126/3, 625 00 Brno, Czech Republic.
- 245 10
- $a Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme / $c O. Majek, J. Danes, M. Skovajsova, H. Bartonkova, L. Buresova, D. Klimes, P. Brabec, P. Kozeny, L. Dusek,
- 520 9_
- $a BACKGROUND: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. METHODS: The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring. RESULTS: Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines. CONCLUSIONS: Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a nádory prsu $x diagnóza $7 D001943
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a podpora zdraví $7 D006293
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mamografie $x využití $7 D008327
- 650 _2
- $a plošný screening $x organizace a řízení $x využití $7 D008403
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a hodnocení programu $7 D015397
- 650 _2
- $a ukazatele kvality zdravotní péče $7 D019984
- 650 _2
- $a registrace $7 D012042
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Danes, Jan
- 700 1_
- $a Skovajsová, Miroslava, $d 1957- $7 xx0010763
- 700 1_
- $a Bartoňková, Helena $7 xx0053127
- 700 1#
- $a Burešová, Lucie. $7 xx0120445
- 700 1#
- $a Klimeš, Daniel. $7 mzk2007417337
- 700 1_
- $a Brabec, Petr
- 700 1_
- $a Kožený, Pavel
- 700 1_
- $a Dušek, Ladislav, $d 1967- $7 mzk2003181727
- 773 0_
- $w MED00008205 $t BMC Public Health $x 1471-2458 $g Roč. 11(20110510), s. 288
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21554747 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20141006173134 $b ABA008
- 999 __
- $a ok $b bmc $g 950373 $s 785677
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 11 $d 288 $e 20110510 $i 1471-2458 $m BMC public health $n BMC Public Health $x MED00008205
- GRA __
- $a NS10650 $p MZ0
- LZP __
- $a Pubmed-20120817/11/04